WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004008286) ARRANGEMENTS AND METHODS FOR TREATING A SUBJECT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/008286    International Application No.:    PCT/US2003/021971
Publication Date: 22.01.2004 International Filing Date: 11.07.2003
IPC:
A61N 5/10 (2006.01)
Applicants: THE GENERAL HOSPITAL CORPORATION [US/US]; 55 Fruit Street, Boston, MA 02144 (US) (For All Designated States Except US).
BORTFELD, Thomas [DE/US]; (US) (For US Only).
THIEKE, Christian [DE/US]; (US) (For US Only).
NIEMIERKO, Andrzej [US/US]; (US) (For US Only)
Inventors: BORTFELD, Thomas; (US).
THIEKE, Christian; (US).
NIEMIERKO, Andrzej; (US)
Agent: ABELEV, Gary; Dorsey & Whitney L.L.P., 250 Park Avenue, New York, NY 10177 (US)
Priority Data:
60/395,496 12.07.2002 US
10/195,910 15.07.2002 US
Title (EN) ARRANGEMENTS AND METHODS FOR TREATING A SUBJECT
(FR) DISPOSITIFS ET PROCEDES POUR TRAITER UN PATIENT
Abstract: front page image
(EN)An arrangement (100) and method for treating the subject (110) are provided, using which it is determined whether an equivalent uniform dose ('EUD') associated with a particular dose distribution is greater than a first dose tolerance associated with a first structure (114) within a subject (110). Also, a determination is made as to whether the EUD associated with the particular dose distribution is greater than a second dose tolerance associated with a second structure (116) within the subject (110).
(FR)L'invention concerne un dispositif et un procédé permettant de traiter le patient, qui consistent à déterminer si une dose uniforme équivalente ('EUD') associée à une distribution de dose particulière est supérieure à une première tolérance de dose associée à une première structure chez un patient. En outre, une détermination est effectuée quant à savoir si la EUD associée à la distribution de dose particulière est supérieure à une seconde tolérance de dose associée à une seconde structure chez un patient.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)